Protein degradation: expanding the toolbox to restrain cancer drug resistance

Despite significant progress in clinical management, drug resistance remains a major obstacle. Recent research based on protein degradation to restrain drug resistance has attracted wide attention, and several therapeutic strategies such as inhibition of proteasome with bortezomib and proteolysis-ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ming, Hui, Li, Bowen, Jiang, Jingwen, Qin, Siyuan, Nice, Edouard C., He, Weifeng, Lang, Tingyuan, Huang, Canhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872387/
https://www.ncbi.nlm.nih.gov/pubmed/36694209
http://dx.doi.org/10.1186/s13045-023-01398-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872387/
https://www.ncbi.nlm.nih.gov/pubmed/36694209
http://dx.doi.org/10.1186/s13045-023-01398-5

Ejemplares similares